{
    "clinical_study": {
        "@rank": "146275", 
        "arm_group": [
            {
                "arm_group_label": "Lymphoma", 
                "description": "Lymphoma patients before and after receiving standard CHOP therapy"
            }, 
            {
                "arm_group_label": "Metastatic Colorectal", 
                "description": "Patients with metastatic colorectal cancer"
            }, 
            {
                "arm_group_label": "Phase 1", 
                "description": "Patients enrolled in Phase 1 clinical trials of new agents, whose mechanism of action is expected to lead to changes in lactate concentration"
            }
        ], 
        "brief_summary": {
            "textblock": "This project is designed to investigate whether measurements of lactate in tumours, made\n      using a magnetic resonance technique similar to MRI, is an effective non-invasive method to\n      detect whether some new targeted drugs are having their desired effect.\n\n      The study hypothesis is that by using magnetic resonance spectroscopy techniques, we will be\n      able to observe changes in tumour lactate levels in vivo, in response to treatment."
        }, 
        "brief_title": "Lactate Imaging as a Tumour Biomarker", 
        "condition": "Cancer", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        Cohort 1:lymphoma patients\n\n          -  minimum lesion size of 2cm\n\n          -  not pre-treated but scheduled to be treated with CHOP (Cyclophosphamide,\n             Hydroxydaunomycin,Oncovin and Prednisilone)\n\n        Cohort 2:Colorectal patients\n\n          -  metastatic disease of at least 2cm\n\n          -  not pre-treated\n\n        Cohort 3:Phase 1 Drug Development\n\n          -  minimum lesion size at least 2cm\n\n        Exclusion Criteria:\n\n          -  MRI incompatible metal implants\n\n          -  Claustrophobia\n\n          -  Inability to tolerate a 40 minute MRI scan"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Primary care clinic"
            }
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "June 17, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01881386", 
            "org_study_id": "13/LO/0536 CCR3939"
        }, 
        "intervention": {
            "arm_group_label": [
                "Lymphoma", 
                "Metastatic Colorectal", 
                "Phase 1"
            ], 
            "description": "Magnetic Resonance Spectroscopy", 
            "intervention_name": "Magnetic Resonance Imaging (MRI)", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Magnetic Resonance Spectroscopy", 
            "Lactate"
        ], 
        "lastchanged_date": "September 3, 2013", 
        "location": {
            "contact": {
                "email": "nandita.desouza@icr.ac.uk", 
                "last_name": "Nandita deSouza, Professor", 
                "phone": "0208 661 3289"
            }, 
            "contact_backup": {
                "email": "katherine.may@rmh.nhs.uk", 
                "last_name": "Katherine May, BSc", 
                "phone": "0208 661 3340"
            }, 
            "facility": {
                "address": {
                    "city": "Sutton", 
                    "country": "United Kingdom", 
                    "state": "Surrey", 
                    "zip": "SM2 5PT"
                }, 
                "name": "The Institute of Cancer Research and Royal Marsden NHS Foundation Trust"
            }, 
            "investigator": {
                "last_name": "Geoffrey Payne, PhD", 
                "role": "Sub-Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United Kingdom"
        }, 
        "number_of_groups": "3", 
        "official_title": "Investigation of Lactate Measured Using Magnetic Resonance Spectroscopy as a Biomarker of Tumour Response", 
        "other_outcome": {
            "measure": "Correlation between changes in post treatment MRS lactate measurements and serum lactate dehydrogenase", 
            "safety_issue": "No", 
            "time_frame": "Baseline and 7 and 21 days post treatment"
        }, 
        "overall_contact": {
            "email": "nandita.desouza@icr.ac.uk", 
            "last_name": "Nandita deSouza, Professor", 
            "phone": "0208 661 3289"
        }, 
        "overall_contact_backup": {
            "email": "katherine.may@rmh.nhs.uk", 
            "last_name": "Katherine May, BSc", 
            "phone": "0208 642 6011", 
            "phone_ext": "4109"
        }, 
        "overall_official": {
            "affiliation": "ICR", 
            "last_name": "Nandita deSouza, Professor", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United Kingdom: Research Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Correlation between changes in MRS lactate measurements at two time points after treatment and clinical response", 
            "safety_issue": "No", 
            "time_frame": "7 and 21 days post treatment"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01881386"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Institute of Cancer Research, United Kingdom", 
            "investigator_full_name": "NdeSouza", 
            "investigator_title": "Professor of Translational Imaging", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "Reproducibility of MRS lactate measurement", 
            "safety_issue": "No", 
            "time_frame": "Two baseline measurements taken at day -7 to 0 pre-treatment"
        }, 
        "source": "Institute of Cancer Research, United Kingdom", 
        "sponsors": {
            "collaborator": {
                "agency": "Cancer Research UK", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Institute of Cancer Research, United Kingdom", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "September 2013"
    }
}